MOXAVAL-CL LB 625 combines Amoxicillin, a potent broad-spectrum antibiotic, with Potassium
Clavulanate, a β-lactamase inhibitor, and Lactic Acid Bacillus, a beneficial probiotic. This
synergistic formulation effectively combats infections while maintaining gut health by
replenishing beneficial bacteria that may be depleted during antibiotic therapy.
Key Benefits:
● Combines antibiotic action with probiotic support to prevent antibiotic-associated
diarrhea
● Effective against a wide range of bacterial infections, including respiratory, urinary, and
soft tissue infections
● Amoxicillin and Potassium Clavulanate work together to overcome resistance from
β-lactamase-producing bacteria
● Lactic Acid Bacillus helps restore healthy gut flora during antibiotic treatment
● Suitable for both acute and chronic bacterial infections
● Convenient tablet formulation for easy administration and patient compliance
Indications:
● Respiratory tract infections (e.g., pneumonia, bronchitis, sinusitis)
● Urinary tract infections (e.g., cystitis, pyelonephritis)
● Skin and soft tissue infections (e.g., cellulitis, abscesses)
● Otitis media, tonsillitis, and other ENT infections
● Prevention of antibiotic-associated gastrointestinal disturbances